AmerM.BeitinjanehMDMPH, MSCR, FACP

Hematology • Miami, FL

University of Miami Sylvester Comprehensive Cancer Center

Join to view full profile

Dr. Beitinjaneh is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Beitinjaneh's full profile

Already have an account?

Office
1475 NW 12th Ave
Miami, FL 33136
Phone+1 305-243-5302

Fax+1 305-243-4975

Education & Training

University of Texas M D Anderson Cancer CenterFellowship, Blood & Bone Marrow Transplant, 2010 - 2011
University of MinnesotaFellowship, Hematology and Medical Oncology, 2007 - 2010
University of Nevada Reno School of MedicineResidency, Internal Medicine, 2004 - 2006
George Washington UniversityInternship, Internal Medicine, 2003 - 2004
University of Tichreen Faculty of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2015 - 2026
VA State Medical License 2011 - 2016
MN State Medical License 2008 - 2012
TX State Medical License 2010 - 2012
NV State Medical License 2006 - 2007
American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
CMS Meaningful Use Stage 1 Certification EpicCare Inpatient - Core EMR, Epic Systems Corporation, 2012

Clinical Trials

Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies Start of enrollment: 2012 Jan 01
Terminated
Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302) Start of enrollment: 2015 Aug 01
Completed
Phase 2
Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Start of enrollment: 2016 Oct 12
Active, not recruiting
Phase 3
Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) Start of enrollment: 2015 Nov 09
Completed
Phase 2
A Study of Acute Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Stem-Cell Transplantation Start of enrollment: 2017 May 14
Terminated
Phase 2
Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies
No longer available
Tabelecleucel for Allogeneic Hematopoietic Cell Transplant Subjects With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab Start of enrollment: 2017 Dec 29
Completed
Phase 3
Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.
Juan Pablo Alderuccio, Alvaro J Alencar, Jonathan H Schatz, Russ A Kuker, Georgios Pongas
The Lancet. Haematology. 2024-12-06
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBAL...
Swaminathan P Iyer, R Alejandro Sica, P Joy Ho, Anca Prica, Jasmine Zain
The Lancet. Oncology. 2024-11-28
Sexual and emotional life among patients with hematological malignancy-Special concerns in low- and middle- income countries (LMICs).
Tamim Alsuliman, Paolo Musiu, Lugien AlAsadi, Ziad Aljarad, Zora Marjanovic
Current Research in Translational Medicine. 2024-11-26

Journal Articles

Comparison of Survival in Patients with T-cell Lymphoma after Autologous and Allogeneic Stem Cell Transplantation as a Frontline Strategy or in Relapsed Disease.
Beitinjaneh A, Saliba RM, Medeiros LJ, Turturro F, Rondon G, Korbling M, Fayad L, Fanale MA, Alousi AM, Anderlini P, Betul O, Popat UR, Pro B, Khouri IF, Biol Blood Marrow Transplant. 2015 Jan 31. pii: S1083-8791(15)00040-3. doi: 10.1016/j.bbmt.2015.01.0

Press Mentions

Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition - Tip SheetNovember 13th, 2024
Sylvester Cancer Researchers Share Findings in Oral Presentations at the ASH 2024 Annual Meeting & Exposition – Tip SheetNovember 13th, 2024
Sylvester Cancer Tip Sheet: Researchers Present Posters at the 66th ASH Annual Meeting & ExpositionNovember 13th, 2024
Join now to see all